Bora Pharmaceuticals Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	1,547	2,981	3,853	3,030	1,392	749.74
Depreciation & Amortization	1,062	1,024	968.8	563.53	285.23	185.31
Other Amortization	62.08	62.08	57.53	42.76	39.95	24.85
Loss (Gain) From Sale of Assets	-8.77	-43.54	27.99	5	3.38	2.22
Asset Writedown & Restructuring Costs	-4.47	151.42	-	-	-	-
Loss (Gain) From Sale of Investments	-391.47	-2,965	-11.56	1,044	47.79	-0.78
Loss (Gain) on Equity Investments	476.63	452.96	0.04	-	-	-
Stock-Based Compensation	73.99	78.62	135.98	102.81	31.83	15.77
Other Operating Activities	1,013	2,317	-833.44	317.17	205.67	309.69
Change in Accounts Receivable	-1,602	1,149	-1,372	2,157	-1,509	-282.39
Change in Inventory	170.9	2,051	-341.82	-124.5	99.39	172.37
Change in Accounts Payable	-155.88	140.29	-663.52	-90.88	107.17	9.81
Change in Unearned Revenue	70.38	131.6	19.31	134.72	-11.77	16.36
Change in Other Net Operating Assets	1,144	-1,285	-505.36	-2,569	1,318	33.68
Operating Cash Flow	3,123	4,504	980.02	4,614	2,010	1,237
Operating Cash Flow Growth	-31.52%	359.54%	-78.76%	129.53%	62.54%	595.56%
Capital Expenditures	-1,110	-928.67	-528.1	-297.71	-194.81	-163.48
Sale of Property, Plant & Equipment	5.96	6.11	12.59	3.37	37.95	0.08
Cash Acquisitions	-1,490	-620.21	-10,265	-999.99	-4,514	-3.83
Divestitures	-1,004	-1,004	-	-	24	-
Sale (Purchase) of Intangibles	-51.55	-43.98	-158.95	-1,132	-5.41	-200.1
Investment in Securities	-1,129	-1,092	422.21	-41.7	323.98	-
Other Investing Activities	1,298	303.68	-162.44	10.92	47.49	141.48
Investing Cash Flow	-3,481	-3,380	-10,680	-2,458	-4,281	-225.85
Short-Term Debt Issued	-	1,370	1,824	-	772.33	-
Long-Term Debt Issued	-	460	15,021	4,804	5,554	100
Total Debt Issued	7,856	1,830	16,844	4,804	6,327	100
Short-Term Debt Repaid	-	-	-	-1,398	-	-572.17
Long-Term Debt Repaid	-	-1,410	-2,910	-5,176	-1,916	-172.03
Total Debt Repaid	-2,496	-1,410	-2,910	-6,574	-1,916	-744.2
Net Debt Issued (Repaid)	5,360	419.37	13,934	-1,769	4,411	-644.2
Issuance of Common Stock	132.36	127.55	94.89	33.94	3.9	66.91
Repurchase of Common Stock	-152.52	-139.26	-389.13	-	-53.09	-
Common Dividends Paid	-1,449	-1,449	-1,233	-619.13	-238.8	-109.77
Other Financing Activities	36.03	-335.65	-336.63	-85.72	471.9	-54.34
Financing Cash Flow	3,927	-1,377	12,071	-2,440	4,595	-741.4
Foreign Exchange Rate Adjustments	551.23	-499.34	404.86	56.13	46.89	-28.63
Net Cash Flow	4,121	-752.31	2,776	-228.03	2,371	240.76
Free Cash Flow	2,014	3,575	451.92	4,316	1,815	1,073
Free Cash Flow Growth	-47.80%	691.04%	-89.53%	137.76%	69.15%	3657.55%
Free Cash Flow Margin	10.30%	18.80%	2.59%	30.39%	17.30%	21.90%
Free Cash Flow Per Share	10.64	18.95	3.20	34.74	15.33	9.19
Levered Free Cash Flow	3,855	2,901	-4,579	3,148	1,037	625.48
Unlevered Free Cash Flow	4,159	3,204	-4,279	3,255	1,105	658.99
Cash Interest Paid	260.08	266.74	382.69	156.01	105.04	54.12
Cash Income Tax Paid	636.67	474.88	1,057	896.47	367.75	18.16
Change in Working Capital	-372.17	2,188	-2,863	-491.94	4.31	-50.16